✦ LIBER ✦

Pharma Firms Push for Sharing of Cancer Trial Data

✍ Scribed by Bhattacharjee, Y.

Book ID: 115525038
Publisher: American Association for the Advancement of Science
Year: 2012
Tongue: English
Weight: 111 KB
Volume: 338
Category: Article
ISSN: 0036-8075
DOI: 10.1126/science.338.6103.29

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

APIXABAN FOR THE TREATMENT OF VENOUS THR

APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS: DATA FROM THE AMPLIFY TRIAL

✍ Agnelli, G.; Buller, H.R.; Cohen, A.; Curto, M.; Gallus, A.S.; Pak, R.; Raskob, 📂 Article 📅 2014 🏛 Pulsus Group Inc 🌐 English ⚖ 196 KB

Shared decision making for prostate canc

Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials

✍ Stacey L Sheridan, Carol Golin… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 233 KB

The Impact of a Novel Computer-Based Dec

The Impact of a Novel Computer-Based Decision Aid on Shared Decision Making for Colorectal Cancer Screening: A Randomized Trial

✍ Schroy, P. C.; Emmons, K.; Peters, E.; Glick, J. T.; Robinson, P. A.; Lydotes, M 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 341 KB

Assessment and data analysis of health-r

Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments

✍ Satoshi Morita; Adrian A. Kaptein; Akira Tsuburaya; Yasuhiro Kodera; Takanori Ma 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 180 KB

Comparison of several model-based method

Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials

✍ Diane L. Fairclough; Harriet F. Peterson; David Cella; Phil Bonomi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

This paper considers five methods of analysis of longitudinal assessment of health related quality of life (QOL) in two clinical trials of cancer therapy. The primary difference in the two trials is the proportion of participants who experience disease progression or death during the period of QOL a

Who should be included in a clinical tri

Who should be included in a clinical trial of screening for bladder cancer? : A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

✍ Andrew J. Vickers; Caroline Bennette; Adam S. Kibel; Amanda Black; Grant Izmirli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB